• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

仅2%的新冠病毒检测呈阳性者携带了社区中传播的90%的病毒。

Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communities.

作者信息

Yang Qing, Saldi Tassa K, Lasda Erika, Decker Carolyn J, Paige Camille L, Muhlrad Denise, Gonzales Patrick K, Fink Morgan R, Tat Kimngan L, Hager Cole R, Davis Jack C, Ozeroff Christopher D, Meyerson Nicholas R, Clark Stephen K, Fattor Will T, Gilchrist Alison R, Barbachano-Guerrero Arturo, Worden-Sapper Emma R, Wu Sharon S, Brisson Gloria R, McQueen Matthew B, Dowell Robin D, Leinwand Leslie, Parker Roy, Sawyer Sara L

机构信息

BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, 80303, USA.

Department of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, 80303, USA.

出版信息

medRxiv. 2021 Mar 5:2021.03.01.21252250. doi: 10.1101/2021.03.01.21252250.

DOI:10.1101/2021.03.01.21252250
PMID:33688663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7941634/
Abstract

We analyze data from the Fall 2020 pandemic response efforts at the University of Colorado Boulder (USA), where more than 72,500 saliva samples were tested for SARS-CoV-2 using quantitative RT-PCR. All samples were collected from individuals who reported no symptoms associated with COVID-19 on the day of collection. From these, 1,405 positive cases were identified. The distribution of viral loads within these asymptomatic individuals was indistinguishable from what has been previously reported in symptomatic individuals. Regardless of symptomatic status, approximately 50% of individuals who test positive for SARS-CoV-2 seem to be in non-infectious phases of the disease, based on having low viral loads in a range from which live virus has rarely been isolated. We find that, at any given time, just 2% of individuals carry 90% of the virions circulating within communities, serving as viral "super-carriers" and possibly also super-spreaders.

摘要

我们分析了美国科罗拉多大学博尔德分校2020年秋季应对疫情期间的数据,当时使用定量逆转录聚合酶链反应对超过72,500份唾液样本进行了新冠病毒检测。所有样本均采集自采集当天报告无新冠相关症状的个体。从中识别出1405例阳性病例。这些无症状个体体内病毒载量的分布与先前有症状个体的报告情况并无差异。无论症状状态如何,基于新冠病毒检测呈阳性的个体中约50%似乎处于疾病的非感染阶段,因为其病毒载量较低,在此范围内很少分离出活病毒。我们发现,在任何给定时间,仅2%的个体携带了社区内传播的90%的病毒粒子,这些个体充当了病毒“超级携带者”,也可能是超级传播者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e261/7941634/d9759c5a56e3/nihpp-2021.03.01.21252250-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e261/7941634/357da1b3a864/nihpp-2021.03.01.21252250-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e261/7941634/753e6935f221/nihpp-2021.03.01.21252250-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e261/7941634/d9759c5a56e3/nihpp-2021.03.01.21252250-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e261/7941634/357da1b3a864/nihpp-2021.03.01.21252250-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e261/7941634/753e6935f221/nihpp-2021.03.01.21252250-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e261/7941634/d9759c5a56e3/nihpp-2021.03.01.21252250-f0003.jpg

相似文献

1
Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communities.仅2%的新冠病毒检测呈阳性者携带了社区中传播的90%的病毒。
medRxiv. 2021 Mar 5:2021.03.01.21252250. doi: 10.1101/2021.03.01.21252250.
2
Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communities.仅有 2%的 SARS-CoV-2 阳性个体携带了在社区中传播的 90%的病毒。
Proc Natl Acad Sci U S A. 2021 May 25;118(21). doi: 10.1073/pnas.2104547118.
3
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
4
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
5
SARS-CoV-2 quantitative real time PCR and viral loads analysis among asymptomatic and symptomatic patients: an observational study on an outbreak in two nursing facilities in Campania Region (Southern Italy).无症状和有症状患者中新型冠状病毒2型定量实时聚合酶链反应及病毒载量分析:对坎帕尼亚大区(意大利南部)两家护理机构疫情的一项观察性研究
Infect Agent Cancer. 2021 Jun 22;16(1):45. doi: 10.1186/s13027-021-00388-x.
6
Clinical Performance of Direct RT-PCR Testing of Raw Saliva for Detection of SARS-CoV-2 in Symptomatic and Asymptomatic Individuals.直接从原始唾液中进行实时 RT-PCR 检测 SARS-CoV-2 以用于有症状和无症状个体的临床检测性能。
Microbiol Spectr. 2022 Dec 21;10(6):e0222922. doi: 10.1128/spectrum.02229-22. Epub 2022 Nov 21.
7
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.一项前瞻性、随机、单盲、交叉试验,旨在研究可穿戴设备对远程早期检测 SARS-CoV-2 感染(COVID-RED)的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jun 22;22(1):412. doi: 10.1186/s13063-021-05241-5.
8
Viral RNA Load and Infectivity of SARS-CoV-2 in Paired Respiratory and Oral Specimens from Symptomatic, Asymptomatic, or Postsymptomatic Individuals.从有症状、无症状或症状后个体的呼吸道和口腔配对标本中检测 SARS-CoV-2 的病毒 RNA 载量和感染力。
Microbiol Spectr. 2022 Jun 29;10(3):e0226421. doi: 10.1128/spectrum.02264-21. Epub 2022 May 16.
9
Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers.无症状 SARS-CoV-2 携带者病毒的脱落。
mSphere. 2021 May 19;6(3):e00019-21. doi: 10.1128/mSphere.00019-21.
10
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.一项前瞻性、随机、单盲、交叉试验,旨在研究可穿戴设备对 SARS-CoV-2 感染(COVID-RED)的远程早期检测的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Oct 11;22(1):694. doi: 10.1186/s13063-021-05643-5.

本文引用的文献

1
Surveillance-to-Diagnostic Testing Program for Asymptomatic SARS-CoV-2 Infections on a Large, Urban Campus in Fall 2020.2020 年秋季,在一个大型城市校园中对无症状 SARS-CoV-2 感染进行监测到诊断测试计划。
Epidemiology. 2022 Mar 1;33(2):209-216. doi: 10.1097/EDE.0000000000001448.
2
Early Viral Clearance and Antibody Kinetics of COVID-19 Among Asymptomatic Carriers.无症状携带者中 COVID-19 的早期病毒清除及抗体动力学
Front Med (Lausanne). 2021 Mar 15;8:595773. doi: 10.3389/fmed.2021.595773. eCollection 2021.
3
Saliva TwoStep for rapid detection of asymptomatic SARS-CoV-2 carriers.
两步唾液检测法快速检测无症状 SARS-CoV-2 携带者。
Elife. 2021 Mar 29;10:e65113. doi: 10.7554/eLife.65113.
4
Equivalent SARS-CoV-2 viral loads by PCR between nasopharyngeal swab and saliva in symptomatic patients.症状性患者鼻咽拭子和唾液中 PCR 检测的 SARS-CoV-2 病毒载量相当。
Sci Rep. 2021 Feb 24;11(1):4500. doi: 10.1038/s41598-021-84059-2.
5
S-Variant SARS-CoV-2 Lineage B1.1.7 Is Associated With Significantly Higher Viral Load in Samples Tested by TaqPath Polymerase Chain Reaction.S 变异株 SARS-CoV-2 谱系 B1.1.7 与 TaqPath 聚合酶链反应检测样本中的病毒载量显著升高相关。
J Infect Dis. 2021 May 28;223(10):1666-1670. doi: 10.1093/infdis/jiab082.
6
Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study.西班牙加泰罗尼亚 282 起聚集性 COVID-19 传播:一项队列研究。
Lancet Infect Dis. 2021 May;21(5):629-636. doi: 10.1016/S1473-3099(20)30985-3. Epub 2021 Feb 2.
7
SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity.唾液直接检测:一个简化且灵活的平台,可提高 SARS-CoV-2 检测能力。
Med. 2021 Mar 12;2(3):263-280.e6. doi: 10.1016/j.medj.2020.12.010. Epub 2020 Dec 26.
8
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.SARS-CoV-2、SARS-CoV 和 MERS-CoV 的病毒载量动态、病毒脱落持续时间和传染性:系统评价和荟萃分析。
Lancet Microbe. 2021 Jan;2(1):e13-e22. doi: 10.1016/S2666-5247(20)30172-5. Epub 2020 Nov 19.
9
Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19.新型冠状病毒肺炎住院患者中可培养的严重急性呼吸综合征冠状病毒2的持续时间。
N Engl J Med. 2021 Feb 18;384(7):671-673. doi: 10.1056/NEJMc2027040. Epub 2021 Jan 27.
10
Incidence and Secondary Transmission of SARS-CoV-2 Infections in Schools.学校中 SARS-CoV-2 感染的发生率和二次传播。
Pediatrics. 2021 Apr;147(4). doi: 10.1542/peds.2020-048090. Epub 2021 Jan 8.